Psychopharmref

Psychopharmref

Psychopharmacology and psychiatry

A look at late-stage candidates, site additions, and recent papers clinicians are discussing.

Oct 2, 2026

•

7 min read

A look at late-stage candidates, site additions, and recent papers clinicians are discussing.

Pipeline drugs, site updates, and recent papers

Jerad Shoemaker MD
Jerad Shoemaker MD
A closer look at new approvals and recent papers

Sep 26, 2026

•

7 min read

A closer look at new approvals and recent papers

A closer look at the approval story, new clinical resources, and papers drawing attention this cycle

Jerad Shoemaker MD
Jerad Shoemaker MD
An evidence-based look at agents in development, new clinical resources, and papers gaining traction this cycle

Sep 18, 2026

•

7 min read

An evidence-based look at agents in development, new clinical resources, and papers gaining traction this cycle

Late-stage candidates, updated site references, and the research clinicians are reading now.

Jerad Shoemaker MD
Jerad Shoemaker MD
A closer look at the approval story, new clinical resources, and papers drawing attention this cycle.

Sep 11, 2026

•

7 min read

A closer look at the approval story, new clinical resources, and papers drawing attention this cycle.

Mechanism, evidence, site updates, and the papers clinicians are discussing now.

Jerad Shoemaker MD
Jerad Shoemaker MD
Regulatory developments and access challenges shaping prescribing, with site updates and high-interest papers from the past six months

Sep 4, 2026

•

7 min read

Regulatory developments and access challenges shaping prescribing, with site updates and high-interest papers from the past six months

Policy and regulatory changes with direct clinical implications, plus the papers getting traction.

Jerad Shoemaker MD
Jerad Shoemaker MD
What is advancing toward approval, new clinical resources, and papers gaining traction this cycle

Aug 28, 2026

•

7 min read

What is advancing toward approval, new clinical resources, and papers gaining traction this cycle

Pipeline drugs worth watching and recent papers

Jerad Shoemaker MD
Jerad Shoemaker MD
Load more